Presentation - Day 2 - Wednesday

Plenary session – Pharmaceutical traceability from manufacturer to patient

Breakout sessions:

  • Panel - Implementation of GS1 standards in clinical trials processes - Dr. Greg Koski, PhD, MD, Chairman of the Board of Directors, Co-Founder & President, CEO, ACRES - Alliance for Clinical Research Excellence and Safety, U.S.; Mr. Hans von Steiger, PMP Group Leader, Clinical Supply Chain Management, Pfizer, U.S.; Ms. Sylvia Bartel, VP Pharmacy, Dana-Farber Cancer Institute, U.S.; Mr. Sylvain Alberola, Head, Clinical Supply Chain Industrial Development, Sanofi, France 
  • Panel - The surge for data and information - Mr. David Brooks, Director of Engineering, Strategic Project Management, Medtronic, U.S.; Mr. Charlie Kim, President and CEO, 121nexus, U.S.; Mr. Feargal Mc Groarty, National Haemophilia System Project Manager, St. James’s Hospital, Ireland; Ms. Tatjana Pathare, Artworks and Regulations Specialist within the Serialisation Project, F. Hoffmann La Roche; Mr. Stefan Artlich, Director, Senior Project Manager 'Track&Trace', Bayer, Germany 
  • Panel - Pharmaceutical Traceability – learnings from around the world - Mr. Senthil Rajaratnam, Affiliate Serialization Account Manager, Eli Lilly and Company, U.S.; Mr. Lloyd Mager, Global Traceability Lead, AbbVie, , U.S.; Mr. Pascal Aulagnet, Senior Manager, Global Serialization - EMEA Client Partner, Pfizer, France; Mr. Stefan Artlich, Director, Track & Trace, Bayer, Germany
  • Panel - UDI – AIDC Implementation experiences - Ms. Jackie Elkin, Global Process Owner Standard Product Identification, Global Regulatory Affairs, Medtronic, U.S.; Mr. John Terwilliger, GS1 Senior Consultant, Global Standards & Serialization Office, Abbott, U.S.; Mr. Mark Hoyle, Technical Director, UDI, Commercial Regulatory Affairs, Teleflex, Ireland; Mr. Georg Keller, Manager Regulatory Affairs, Labelling Coordinator, B.Braun / Aesculap AG, Germany